Drug intelligence / Profile preview

JG342

Development stage
Preclinical
Lead developer
University of Michigan
Modality
Small Molecules
Administration
Intravenous (preclinical)
01

Overview

JG342 is the code name for at least two distinct products depending on context. The primary pharmaceutical context refers to JG342 as an experimental small molecule allosteric inhibitor of HSP70 (heat shock protein 70), researched for its activity against multiple myeloma cell lines, particularly those resistant to proteasome inhibitors like bortezomib. JG342 acts by disrupting the chaperone function of HSP70, perturbing mitochondrial proteostasis and inducing apoptosis in malignant plasma cells. It has shown increased potency compared to related compounds in vitro and some in vivo activity but faces challenges in balancing efficacy and toxicity, especially in murine models. In a medical device context, "JG342" is used to designate a specific silicone clamp or silicone holder (8.5 mm, 5/16”) within Aesculap/B. Braun sterile container surgical supply systems, not a pharmaceutical product[1][7][8].

02

Targets

HSPA1A (HSP70-1A)

Beyond the preview

Go deeper on JG342.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JG342.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call